Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Free Report) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totaling 120 shares. Based on an average daily volume of 2,132 shares, the short-interest ratio is currently 0.1 days.
Algernon Pharmaceuticals Stock Performance
Shares of OTCMKTS:AGNPF opened at $0.24 on Monday. The stock has a 50 day moving average of $0.31 and a 200 day moving average of $0.22. Algernon Pharmaceuticals has a 12-month low of $0.22 and a 12-month high of $0.64.
Algernon Pharmaceuticals Company Profile
Algernon Pharmaceuticals is a Canadian clinical-stage pharmaceutical development company focused on researching and developing therapies for unmet medical needs. The company’s strategy has centered on drug repurposing, which involves evaluating previously studied compounds for potential use in new disease indications.
Its research programs have included NP-120, an ifenprodil-based therapy investigated for conditions such as idiopathic pulmonary fibrosis and other serious respiratory diseases.
Featured Articles
- Five stocks we like better than Algernon Pharmaceuticals
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Algernon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Algernon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
